HR Data Analytics Specialist at Legend Biotech

Ghent, Flanders, Belgium

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, Human ResourcesIndustries

Requirements

Master’s degree in HRM, Business Administration, Data Analytics, or equivalent through experience
Minimum 2 years in HR data analysis, ideally in payroll or rewards
Fluent in Dutch and English
Strong analytical skills and experience with Excel, Power BI, Tableau, SQL
Familiarity with HR systems like Protime, eBlox, and Workday is a plus
Solid understanding of HR processes and data governance
Clear communicator—able to simplify complex data
Detail-oriented and proactive
Collaborative mindset with a service-oriented approach

Responsibilities

Collect, clean, structure, and analyze HR-related data on payroll, benefits, absences, and personnel costs to enable data-driven decision-making
Develop and maintain HR dashboards and targeted reports using tools such as Excel, Power BI, or Tableau
Provide company-level reporting (headcount, payroll costs, absences, turnover) and structured evaluations of HR initiatives to support HR strategy and strategic management decision-making
Analyze and monitor trends and anomalies in compensation, absenteeism, fringe benefits, and employee mobility
Apply predictive analytics to identify potential future risks early
Optimize existing reporting processes, including automation, standardization, and quality control
Partner with HR Business Partners and Compensation & Benefits team to interpret analytical findings (e.g., pay equity gaps, absenteeism spikes, or mobility trends) and co-develop actionable plans such as policy adjustments, targeted interventions, or process optimizations
Support HR audits
Identify automation opportunities within HR processes
Contribute to data governance and standardization of HR data
Actively support the implementation of new HR data systems, including testing, data migration, user feedback, and training
Act as a bridge between HR, IT, and Finance for data-related projects
Document data processes
Identify and introduce AI and machine learning applications, specifically for HR
Contribute and support the international HRIS roll-outs for Europe in collaboration with Global HR Operations
Ensure data quality, compliance, and security of employee information across HR systems
Act as a functional expert for Workday within the Belgium HR team
Support EU end users in using Workday

Skills

Excel

Power BI

Tableau

Data Analysis

Data Cleaning

HR Reporting

Dashboards

Predictive Analytics

Payroll Analysis

Compensation Analysis

Trend Analysis

Automation

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Franklin Township, New JerseyHeadquarters

2014Year Founded

$146.4MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Paid Sick Leave

Paid Holidays

Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.

Collaboration with Multiply Labs may face technological challenges, delaying production timelines.

Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.

The company is technology agnostic, exploring multiple platforms for effective cancer treatments.

Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.

New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.

Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI

Try Jobo Free